Altimmune to present at the h.c. wainwright 23rd annual global investment conference september 13-15, 2021

Gaithersburg, md., sept. 07, 2021 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the h.c. wainwright 23rd annual global investment conference, being held virtually on september 13-15, 2021.

ALT Ratings Summary

ALT Quant Ranking